Page 8 - Bio Techne News Today

Bio-Techne (NASDAQ:TECH – Get Free Report) and Valneva (NASDAQ:VALN – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, dividends, analyst recommendations, institutional ownership, valuation and profitability. Profitability This table compares Bio-Techne and Valneva’s net margins, return […]

Bio-Techne (NASDAQ:TECH – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Monday. A number of other equities research analysts also recently issued reports on the stock. William Blair began coverage on shares of Bio-Techne in a research note on Monday, August […]

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Inceptionr LLC purchased a new position in Bio-Techne Co. (NASDAQ:TECH – Free Report) during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 27,715 shares of the biotechnology company’s stock, valued at approximately $2,056,000. Bio-Techne accounts for about 0.7% of Inceptionr LLC’s portfolio, making […]

Blair William & Co. IL lifted its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 0.3% during the 1st quarter, Holdings Channel reports. The fund owned 114,661 shares of the biotechnology company’s stock after acquiring an additional 353 shares during the quarter. Blair William & Co. IL’s holdings in Bio-Techne were worth $8,507,000 at […]

William Blair began coverage on shares of Bio-Techne (NASDAQ:TECH – Free Report) in a research report released on Monday morning, MarketBeat reports. The firm issued an outperform rating on the biotechnology company’s stock. William Blair also issued estimates for Bio-Techne’s Q1 2024 earnings at $0.40 EPS, Q2 2024 earnings at $0.40 EPS, Q3 2024 earnings […]

Itau Unibanco Holding S.A. boosted its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 322.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,621 shares of the biotechnology company’s stock after acquiring an additional 5,052 shares during the period. […]

Understanding the intrinsic value of Bio-Techne Corp (TECH) and its investment potential

Delving into the financial growth, competitive edges, and market outperformance of Bio-Techne Corp (TECH)

Bio-Techne Co. (NASDAQ:TECH – Get Free Report) shares traded down 2% during trading on Monday . The stock traded as low as $77.54 and last traded at $78.57. 184,823 shares traded hands during trading, a decline of 81% from the average session volume of 979,527 shares. The stock had previously closed at $80.16. Wall Street […]